William Grosh is an Oncology physician affiliated with University of Virginia. OpenAlex indexes 94 publications with 2,766 citations (h-index 26); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Low-dose Interleukin-2 and Pembrolizumab in Melanoma and Renal Cell Cancer
Sponsor: William Grosh, MD
- Paclitaxel and GM-CSF in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed By Surgery
Sponsor: University of Virginia
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
NIH funding
1 NIH research award on record, funded 1993–2009 per NIH RePORTER. The latest:
- EVALOF IMMUNE STATUS FOLLOWING THE ADMINISTRATION OF CHEMOTHERAPY OR STEROIDS
University of Virginia
FY2009$2,925M01RR000847 - EVALOF IMMUNE STATUS FOLLOWING THE ADMINISTRATION OF CHEMOTHERAPY OR STERIODS
University of Virginia
FY2008$6,895M01RR000847
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Stephen Caldwell, MD
University of Virginia
Mark Deboer, MD
University of Virginia
Jaideep Kapur, MD
University of Virginia
Mark Quigg, MD, MSc
University of Virginia
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Larry Norton, MD
Memorial Sloan Kettering Cancer Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”